Reuters logo
BRIEF-Regeneron announces agreement with BARDA
August 22, 2016 / 12:46 PM / a year ago

BRIEF-Regeneron announces agreement with BARDA

Aug 22 (Reuters) - Regeneron Pharmaceuticals Inc

* Regeneron announces agreement with BARDA for the manufacturing and testing of new antibodies against MERS virus

* HHS will provide funding to regeneron of up to $8.9 million

* HHS funding to be used for preparation and submission of an investigational new drug application with FDA

* In addition to programs in MERS and Ebola, also “quickly progressing” a preclinical program targeting zika virus Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below